W102-19: Psychopharmacology for Persons with Alzheimer's and Other Dementias

4.73 (15 votes)

W102-19:  Psychopharmacology for Persons with Alzheimer's and Other Dementias

This session provides clarity on the varying types of dementias known to occur. Current research and treatment guidelines for Alzheimer’s disease are presented in detail.

  Pierre Tariot, MD

Disclosures:  The speaker has indicated a significant financial interest or other affiliation with the following: Consulting fees: Acadia, Abbott Laboratories, AbbVie, AC Immune, Auspex, Boehringer-Ingelheim, Brain Test Inc., California Pacific Medical Center, Chase Pharmaceuticals, Eisai, GliaCure, Insys Therapeutics, Pfizer, T3D; Consulting fees and research support: AstraZeneca, Avanir, Lilly, Lundbeck, Merck & Co., Roche, Takeda; Research support only: Amgen, Avid, Biogen, Functional Neuromodulation (f(nm)), GE, Genentech, Novartis; Other research support: NIA, Arizona Department of Health Services, Alzheimer's Association, Banner Alzheimer’s Foundation, FBRI, GHR, Nomis Foundation, Flinn Foundation, Geoffrey Beene Foundation; Patents: Contributor to a patent owned by the University of Rochester, “Biomarkers of Alzheimer’s Disease.”; Stocks: Owner of stock options in Adamas Pharmaceuticals. Off-label use of medications will be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

Session Length:
  1 hour 26 minutes

Target Audience:  APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

  1. Explore a systematic approach to differential diagnosis of the dementias, the deployment of cognitive enhancers for Alzheimer’s disease, and evaluate both non-pharmacological and pharmacological management of neuropsychiatric features of dementia.
  2. Discuss the emerging drug treatment landscape for treatment and prevention of dementia.

Keywords:  Psychopharmacology, Alzheimer’s, Dementia

Continuing Nursing Education:
1.5 pharmacology contact hours.  *In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA Clinical Psychopharmacology Institute - West
San Diego, CA
Saturday, March 16, 2019
1:45pm – 3:15pm

The contact hours for this session expire:  June 30, 2021

Components visible upon registration.